US Stocks
/
Fractyl Health, Inc. Share Price

Fractyl Health, Inc. Share Price

NASDAQ: GUTS | Micro Cap
$0.69
-$0.00 (-0.55%) Last updated on 07 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Fractyl Health, Inc. Stock Performance

Open
$0.69
Prev. Close
$0.69
Circuit Range
N/A
Day Range
$0.69 - $0.71
Year Range
$0.38 - $2.44
Volume
8,684
Average Traded
$0.70

Fractyl Health, Inc. Share Price Today

As of 9 August 2026, Fractyl Health, Inc.'s share price is $0.69. The stock opened at $0.69, compared to its previous close of $0.69. During today's trading session, Fractyl Health, Inc.'s share price traded between $0.69 and $0.71, with an average price of $0.70. Over the past 52 weeks, the stock has recorded a high of $2.44 and a low of $0.38. In terms of performance, Fractyl Health, Inc.'s share price has risen by 48.06% over the last six months and is down 28.65% on a year-on-year basis.

Fractyl Health, Inc. Share Price Chart

$0.69$0.71
L
Show Current Price
H

Fractyl Health, Inc. Stock Fundamentals & Key Indicators

Market Cap
$52.20M
PE Ratio (TTM)
-0.37
Dividend Yield
N/A
EPS (TTM)
$-1.86
Revenue (TTM)
N/A
Return On Equity (TTM)
-1490.32%
Profit Margin
N/A
Debt to Equity
1.94
Quarterly Earnings Growth YoY
-614.48%

Fractyl Health, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025
RevenueN/A-$24000.00-$7000.00N/A
Net Profit-$3.32M-$17.23M-$23.17M-$23.73M
Net Profit MarginN/A71787.50%331042.86%N/A
Income ChangeN/A-418.63%-34.50%-2.43%

About Fractyl Health, Inc.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Fractyl Health, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.69
$0.69
-0.43%
Jul 2026
$0.81
$0.69
-12.64%
Jun 2026
$0.79
$0.79
-1.86%
May 2026
$0.64
$0.81
+27.73%
Apr 2026
$0.45
$0.63
+38.07%
Mar 2026
$0.46
$0.46
-1.72%
Feb 2026
$0.50
$0.47
-0.43%
Jan 2026
$2.25
$0.47
-78.82%
Dec 2025
$1.54
$2.21
+40.89%
Nov 2025
$1.23
$1.56
+26.72%
Oct 2025
$1.65
$1.24
-21.84%
Sep 2025
$0.96
$1.58
+63.73%

GUTS Share Price FAQs

What is Fractyl Health, Inc. share price today?

chevron-up
Fractyl Health, Inc. share price today is $0.69 as on August 7, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Fractyl Health, Inc. stock?

chevron-up
The 52 week high of Fractyl Health, Inc. stock is $2.44, while the 52 week low is $0.38 as of 7 Aug '26.

What is GUTS's market capitalisation today?

chevron-up
GUTS market capitalisation is $52.20M as of August 9, 2026, at 10:17 pm IST.

What is GUTS's net income for the last quarter?

chevron-up
GUTS's net income for the last quarter is -0.02B USD.

What is the 5 year returns of GUTS?

chevron-up
The 5 year returns of GUTS is -92.35% as on 7 Aug '26.

What is the high & low stock price of GUTS today?

chevron-up
GUTS stock price hit a high of $0.71 and low of $0.69 as of 7 Aug '26.

Can I buy GUTS shares in India?

chevron-up
Yes. You can buy GUTS in India by opening an international trading account.